NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ECM Therapeutics, Inc.

ECM Therapeutics, Inc.

Private
PennsylvaniaHealthcare & Life Scienceshttps://ecmtherapeutics.com/

Last Round

VC Round

May 28, 2018

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ECM Therapeutics, Inc. is a biotechnology company that develops and manufactures therapeutic products derived from extracellular matrix (ECM) for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineextracellular matrixECMinjectable hydrogeltissue restorationanorectal fistula treatmentbiomaterialstissue engineeringnon-surgical therapycell-free therapyclinical-stage biotechbiologics manufacturingmatrix-bound nanovesiclesMBV platformadvanced wound careocular repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ECM Therapeutics, Inc. Comparables

Compare ECM Therapeutics, Inc. with similar companies based on industry and business-model similarity.

ECM Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

ECM Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 28, 2018
View all Funding Rounds

Key People

Founding team and executive leadership

Paul Fagan

Chief Executive Officer

Executive Team

ECM Therapeutics, Inc. Investors

Notable investors and investment history

ECM Therapeutics, Inc. investors
InvestorRounds
University of PittsburghVC Round
Kineticos VenturesVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 39% MoM, reaching 2.4K.

  • May 28, 2018

    $35.2M round with participation from Kineticos Ventures.

View all signals

ECM Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ECM Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ECM Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPennsylvania
Employee Range9
Year Founded2018
Last FundingMay 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.